chr1-56867638-C-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000361249.4(C8A):c.107C>A(p.Ala36Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0137 in 1,613,714 control chromosomes in the GnomAD database, including 732 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A36V) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000361249.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C8A | NM_000562.3 | c.107C>A | p.Ala36Glu | missense_variant | 2/11 | ENST00000361249.4 | NP_000553.1 | |
C8A | XM_017002234.2 | c.107C>A | p.Ala36Glu | missense_variant | 2/8 | XP_016857723.1 | ||
C8A | XM_011542079.3 | c.107C>A | p.Ala36Glu | missense_variant | 2/8 | XP_011540381.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C8A | ENST00000361249.4 | c.107C>A | p.Ala36Glu | missense_variant | 2/11 | 1 | NM_000562.3 | ENSP00000354458 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00890 AC: 1354AN: 152182Hom.: 52 Cov.: 32
GnomAD3 exomes AF: 0.0196 AC: 4928AN: 251026Hom.: 238 AF XY: 0.0252 AC XY: 3414AN XY: 135648
GnomAD4 exome AF: 0.0142 AC: 20753AN: 1461414Hom.: 680 Cov.: 31 AF XY: 0.0174 AC XY: 12666AN XY: 727028
GnomAD4 genome AF: 0.00889 AC: 1354AN: 152300Hom.: 52 Cov.: 32 AF XY: 0.00999 AC XY: 744AN XY: 74460
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Type I complement component 8 deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 21, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at